|
Dawn Viveash has served as Vice President, Regulatory Affairs and Safety since November 2006. Prior to joining us, Dr. Viveash managed her own consulting business, providing clinical development, regulatory affairs and safety guidance to biopharmaceutical companies. Her experience includes all stage of development and product commercialization and she has worked with small molecules and biologics. From 2000 to 2002, she was Vice President, Regulatory Affairs, Professional Services and Safety of Immunex until its merger with Amgen at which point she became Vice President of Regulatory Affairs and Safety for Amgen. From 1995 to 1998, she was the Chief Safety Officer and Vice President for Global Pharmacovigilance for Pharmacia and The Upjohn Company in the US. She joined the pharmaceutical industry in 1986 as a drug development physician for Upjohn in the UK. Dr. Viveash received her training in Pharmacy and subsequently Medicine from London University, UK. She practiced internal medicine for a number of years and became a Member of the Royal College of Physicians. | 